• New diagnosis codes for COVID-19 immunization status 

    The Centers for Disease Control and Prevention (CDC) and the Centers for Medicare & Medicaid Services have announced three new diagnosis codes, including two for COVID-19 immunization status. The following codes will be available as of April 1:

    ICD-10-CM                 Description

    Z28.310                       Unvaccinated for COVID-19

    Z28.311                       Partially vaccinated for COVID-19

    Z28.39                        Other under-immunization status

    According to ICD-10-CM guidelines, clinicians may assign code Z28.310, “Unvaccinated for COVID-19,” when the patient has not received a dose of any COVID-19 vaccine. Clinicians may assign code Z28.311, “Partially vaccinated for COVID-19,” when the patient has received at least one dose of a multi-dose COVID-19 vaccine regimen, but has not received the doses necessary to meet the CDC definition of “fully vaccinated” at the time of the encounter. (For information on what constitutes “fully vaccinated,” visit the CDC’s website.) New code Z28.39 is for reporting when a patient is not current on other, non-COVID vaccines. 

    Per the ICD-10-CM table, “These codes should not be used for individuals who are not eligible for the COVID-19 vaccines, as determined by the health care provider.” The index and tabular addenda for the new diagnosis codes are also available on the CDC website.  

    — Kent Moore, senior strategist for physician payment, American Academy of Family Physicians

    Posted on March 7, 2022, by Kent Moore



    Disclaimer: The opinions and views expressed here are those of the authors and do not necessarily represent or reflect the opinions and views of the American Academy of Family Physicians. This blog is not intended to provide medical, financial, or legal advice. Some payers may not agree with the advice given. This is not a substitute for current CPT and ICD-9 manuals and payer policies. All comments are moderated and will be removed if they violate our Terms of Use.